Genitourinary Cancer News

The combination of cabozantinib and nivolumab showed promising efficacy for certain patients with metastatic non-clear cell renal cell carcinoma, according to phase 2 study results presented at International Kidney Cancer Symposium.

Unemployment appeared associated with a lower likelihood of having health insurance and of being up to date on cancer screening tests, according to results of a study published in Cancer.

Radiation prior to combination immunotherapy did not influence clinical outcomes among patients with metastatic renal cell carcinoma and bone metastases, according to study results presented at International Kidney Cancer Symposium.

COVID-19 vaccination appeared safe for patients with renal cell carcinoma receiving immune checkpoint inhibitors, according to retrospective study results presented at International Kidney Cancer Symposium.

Patients with AKI may continue treatment with immune checkpoint inhibitors, even if they have experienced immune checkpoint inhibitor-AKI, according to data published in the Journal for ImmunoTherapy of Cancer.

The economic burden of cancer care in the United States remained heavy for patients, who incurred more than $21 billion in costs in 2019, according to part two of the Annual Report to the Nation on the Status of Cancer.

A personalized approach to radiation therapy can maximize therapeutic effect across multiple cancer types, according to findings published in The Lancet Oncology.

Although cervical cancer elimination appears to be within reach in the United States, a predictive model anticipated an approximately decade-long gap between low-poverty and high-poverty areas of the country in achieving this goal.

Patients with neuroendocrine tumors are at greater risk for cancer-associated death compared with death due to other causes; however, mortality rates vary according to tumor site.

Use of personalized interventions significantly reduced grade 3 or higher chemotherapy-related toxicity among patients with cancer aged 65 years or older, randomized trial results showed.